Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Diagnosis and Management of Atopic Dermatitis

Diagnosis

  • The American Academy of Dermatology recommends that diagnosis is primarily clinical, based on characteristic features including intense pruritus, eczematous lesions, chronic/relapsing disease course, and personal or family history of atopy 1, 3
  • Eczematous lesions typically display symmetrical and age-specific distribution pattern in infants, commonly affecting cheeks, scalp, extensor surfaces of extremities 1, 4
  • Approximately 80% of patients with atopic dermatitis develop symptoms within the first 5 years of life 1, 3

Treatment Approach

  • The American Academy of Pediatrics recommends applying fragrance-free emollients regularly to maintain skin barrier integrity, which is essential for all infants with atopic dermatitis regardless of disease severity 5, 2
  • The National Eczema Association suggests using lukewarm water with gentle, soap-free cleansers, followed immediately by application of emollients to lock in moisture 5, 2
  • Identify and eliminate potential triggers such as irritants, allergens, excessive sweating, changes in temperature or humidity, and stress 1, 2
  • Provide comprehensive education to parents about proper skin care routine and the chronic, relapsing nature of atopic dermatitis 2

Topical Anti-inflammatory Treatment

  • For mild to moderate flares, use low-potency topical corticosteroids, such as 1% hydrocortisone, as recommended by the American Academy of Dermatology 2
  • Apply a thin layer of topical corticosteroid to affected areas only, not as a general moisturizer 2
  • Avoid high-potency corticosteroids in infants due to increased risk of adrenal suppression 1, 2

Stepwise Treatment Based on Severity

Mild Atopic Dermatitis

  • Basic therapy with emollients and trigger avoidance, as recommended by the National Eczema Association 5, 2
  • Reactive therapy with low-potency topical corticosteroids during flares 5, 2

Moderate Atopic Dermatitis

  • Basic therapy with emollients and trigger avoidance 5, 2
  • Proactive and reactive therapy with low-potency topical corticosteroids 5, 2
  • Consider topical PDE-4 inhibitor, such as crisaborole, for patients aged 3 months and above as an alternative to corticosteroids 2, 6

Severe to Very Severe Atopic Dermatitis

  • Basic therapy with emollients and trigger avoidance 5, 2
  • Proactive and reactive therapy with low to medium potency topical corticosteroids 5, 2
  • Consider wet-wrap therapy with topical corticosteroids for short periods 1, 3, 2
  • Oral antihistamines may be used as adjuvant therapy primarily for their sedative properties to help with sleep disturbance during severe flares 6, 2

Important Considerations and Precautions

  • Long-term application of topical antibiotics is not recommended due to increased risk of resistance and skin sensitization, as advised by the Centers for Disease Control and Prevention 6, 2
  • Topical calcineurin inhibitors are not approved for infants under 2 years old 2
  • Topical PDE-4 inhibitors, such as crisaborole, have been approved for patients aged 3 months and above for mild to moderate atopic dermatitis 6, 2
  • Phototherapy is not recommended for children younger than 12 years as long-term safety remains unclear 6, 5
  • Consider referral to a specialist if the condition worsens despite appropriate first-line management, if there are signs of suspected secondary infection not responding to treatment, or for consideration of more advanced therapies in severe cases 2

Common Pitfalls to Avoid

  • Using high-potency topical corticosteroids in infants, which increases risk of adrenal suppression, as warned by the American Academy of Pediatrics 1, 2
  • Applying topical corticosteroids as general moisturizers rather than targeting affected areas only 2
  • Neglecting basic therapy with regular emollient application, which is essential regardless of disease severity, as emphasized by the National Eczema Association 5, 2
  • Long-term use of topical antibiotics, which increases risk of resistance and skin sensitization, as cautioned by the Centers for Disease Control and Prevention 6, 2
  • Failing to educate parents about the chronic, relapsing nature of atopic dermatitis and proper skin care routine, as recommended by the American Academy of Pediatrics 2